Published on:
Kevin Hagan, president and CEO of the PAN Foundation, spoke to PharmExec about the recent IRA changes that impact Medicare, as well as the Foundation’s near-term goals.
Kevin Hagan, president and CEO of the PAN Foundation, participated on the Pharma USA 2023 panel “Post-Inflation Reduction Act: The continued need for patient assistance.” Here he speaks to Pharmaceutical Executive about the IRA’s impact on how the Foundation will address its near- and longer-term goals.
Source link
#Medicare #Reform #Means #Patient #Access #Network #Foundation
